Immortalized Schwann cell lines as useful tools for pathogenesis-based therapeutic approaches to diabetic peripheral neuropathy
Growing evidence suggests that hyperglycemia-related abnormalities in Schwann cells play a pivotal role in the development and progression of diabetic peripheral neuropathy (DPN). Several immortalized Schwann cell lines have been established in our laboratory and utilized for the study of DPN; IMS32...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-01-01
|
| Series: | Frontiers in Endocrinology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2024.1531209/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832592653296861184 |
|---|---|
| author | Kazunori Sango Hideji Yako Hideji Yako Naoko Niimi Shizuka Takaku |
| author_facet | Kazunori Sango Hideji Yako Hideji Yako Naoko Niimi Shizuka Takaku |
| author_sort | Kazunori Sango |
| collection | DOAJ |
| description | Growing evidence suggests that hyperglycemia-related abnormalities in Schwann cells play a pivotal role in the development and progression of diabetic peripheral neuropathy (DPN). Several immortalized Schwann cell lines have been established in our laboratory and utilized for the study of DPN; IMS32 from normal ICR mice, 1970C3 from normal C57BL/6 mice, IWARS1 and IKARS1 from wild-type and aldose reductase-deficient C57BL/6 mice, and IFRS1 from normal Fischer 344 rats. These cell lines retain biological features of Schwann cells and display high proliferative activities that enable us to perform molecular and biochemical analyses. In addition, these cells have exhibited metabolic alterations under exposure to diabetes-associated conditions, such as hyperglycemia, dyslipidemia, glycative and oxidative stress load. Herein, recent studies with these cell lines regarding the pathogenic factors of DPN (augmentation of the polyol and other collateral glycolysis pathways, glycative and oxidative stress-induced cell injury, autophagic and proteostatic disturbances, etc.) and therapeutic strategies targeting these factors are introduced. |
| format | Article |
| id | doaj-art-84d86cbfd15345d087c9be3881c2d025 |
| institution | Kabale University |
| issn | 1664-2392 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Endocrinology |
| spelling | doaj-art-84d86cbfd15345d087c9be3881c2d0252025-01-21T05:43:34ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922025-01-011510.3389/fendo.2024.15312091531209Immortalized Schwann cell lines as useful tools for pathogenesis-based therapeutic approaches to diabetic peripheral neuropathyKazunori Sango0Hideji Yako1Hideji Yako2Naoko Niimi3Shizuka Takaku4Diabetic Neuropathy Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, JapanDiabetic Neuropathy Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, JapanLaboratory of Molecular Neuroscience and Neurology, Tokyo University of Pharmacy and Life Sciences, Tokyo, JapanDiabetic Neuropathy Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, JapanDiabetic Neuropathy Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, JapanGrowing evidence suggests that hyperglycemia-related abnormalities in Schwann cells play a pivotal role in the development and progression of diabetic peripheral neuropathy (DPN). Several immortalized Schwann cell lines have been established in our laboratory and utilized for the study of DPN; IMS32 from normal ICR mice, 1970C3 from normal C57BL/6 mice, IWARS1 and IKARS1 from wild-type and aldose reductase-deficient C57BL/6 mice, and IFRS1 from normal Fischer 344 rats. These cell lines retain biological features of Schwann cells and display high proliferative activities that enable us to perform molecular and biochemical analyses. In addition, these cells have exhibited metabolic alterations under exposure to diabetes-associated conditions, such as hyperglycemia, dyslipidemia, glycative and oxidative stress load. Herein, recent studies with these cell lines regarding the pathogenic factors of DPN (augmentation of the polyol and other collateral glycolysis pathways, glycative and oxidative stress-induced cell injury, autophagic and proteostatic disturbances, etc.) and therapeutic strategies targeting these factors are introduced.https://www.frontiersin.org/articles/10.3389/fendo.2024.1531209/fullimmortalized Schwann cellsdiabetic peripheral neuropathypolyol pathwayglycationoxidative stressautophagic and proteostatic disturbances |
| spellingShingle | Kazunori Sango Hideji Yako Hideji Yako Naoko Niimi Shizuka Takaku Immortalized Schwann cell lines as useful tools for pathogenesis-based therapeutic approaches to diabetic peripheral neuropathy Frontiers in Endocrinology immortalized Schwann cells diabetic peripheral neuropathy polyol pathway glycation oxidative stress autophagic and proteostatic disturbances |
| title | Immortalized Schwann cell lines as useful tools for pathogenesis-based therapeutic approaches to diabetic peripheral neuropathy |
| title_full | Immortalized Schwann cell lines as useful tools for pathogenesis-based therapeutic approaches to diabetic peripheral neuropathy |
| title_fullStr | Immortalized Schwann cell lines as useful tools for pathogenesis-based therapeutic approaches to diabetic peripheral neuropathy |
| title_full_unstemmed | Immortalized Schwann cell lines as useful tools for pathogenesis-based therapeutic approaches to diabetic peripheral neuropathy |
| title_short | Immortalized Schwann cell lines as useful tools for pathogenesis-based therapeutic approaches to diabetic peripheral neuropathy |
| title_sort | immortalized schwann cell lines as useful tools for pathogenesis based therapeutic approaches to diabetic peripheral neuropathy |
| topic | immortalized Schwann cells diabetic peripheral neuropathy polyol pathway glycation oxidative stress autophagic and proteostatic disturbances |
| url | https://www.frontiersin.org/articles/10.3389/fendo.2024.1531209/full |
| work_keys_str_mv | AT kazunorisango immortalizedschwanncelllinesasusefultoolsforpathogenesisbasedtherapeuticapproachestodiabeticperipheralneuropathy AT hidejiyako immortalizedschwanncelllinesasusefultoolsforpathogenesisbasedtherapeuticapproachestodiabeticperipheralneuropathy AT hidejiyako immortalizedschwanncelllinesasusefultoolsforpathogenesisbasedtherapeuticapproachestodiabeticperipheralneuropathy AT naokoniimi immortalizedschwanncelllinesasusefultoolsforpathogenesisbasedtherapeuticapproachestodiabeticperipheralneuropathy AT shizukatakaku immortalizedschwanncelllinesasusefultoolsforpathogenesisbasedtherapeuticapproachestodiabeticperipheralneuropathy |